Clinical Trials in Sherwood Park, Alberta

Find clinical trials in Sherwood Park, Alberta. Discover local research opportunities and treatment options in your area.

9 Active Trials Found in Sherwood Park

Showing 9 trials on this page

Page 1 of 1

A Study to Evaluate the Efficacy, Safety, and Tolerability of BMS-986278 in Participants With Progressive Pulmonary Fibrosis

NCT ID: NCT06025578

This clinical trial is studying a new medication called BMS-986278 to see how well it works, how safe it is, and how well patients tolerate it for people with a condition called Progressive Pulmona...

Recruiting

Phase: PHASE3 Conditions: Progressive Pulmonary Fibrosis

A Study Evaluating the Efficacy of Budesonide, Glycopyrronium and Formoterol Fumarate Metered Dosed Inhaler on Cardiopulmonary Outcomes in Chronic Obstructive Pulmonary Disease

NCT ID: NCT06283966

This clinical trial is studying a new inhaler that combines three medications—budesonide, glycopyrronium, and formoterol—to see how well it works in improving heart and lung health in people with C...

Recruiting

Phase: PHASE3 Conditions: COPD (Chronic Obstructive Pulmonary Disease)

A Study to Find Out Whether BI 765423 Has an Effect on Lung Function in People With Idiopathic Pulmonary Fibrosis (IPF) With or Without Standard Treatment

NCT ID: NCT07036523

This clinical trial is studying a new medicine called BI 765423 to see if it can help improve lung function in adults with idiopathic pulmonary fibrosis (IPF), a lung condition that causes scarring...

Not yet recruiting

Phase: PHASE2 Conditions: Idiopathic Pulmonary Fibrosis

Phase III Study Investigating Heart Failure and Cardiovascular Death With Baxdrostat in Combination With Dapagliflozin

NCT ID: NCT06677060

This clinical trial is studying the effects of a medication called Baxdrostat combined with Dapagliflozin on heart failure and cardiovascular death in adults aged 40 and older who have type 2 diabe...

Recruiting

Phase: PHASE3 Conditions: Heart Failure

A Study to Evaluate the Efficacy, Safety, and Tolerability of BMS-986278 in Participants With Idiopathic Pulmonary Fibrosis

NCT ID: NCT06003426

This clinical trial is looking at a new medication called BMS-986278 to see how well it works, how safe it is, and how well people can tolerate it in those suffering from Idiopathic Pulmonary Fibro...

Recruiting

Phase: PHASE3 Conditions: Idiopathic Pulmonary Fibrosis

A Study to Evaluate Astegolimab in Participants With Chronic Obstructive Pulmonary Disease

NCT ID: NCT05595642

This clinical trial is studying a new medication called astegolimab to see how well it works and how safe it is for people with Chronic Obstructive Pulmonary Disease (COPD). This study is specifica...

Recruiting

Phase: PHASE3 Conditions: Chronic Obstructive Pulmonary Disease (COPD)

A Study to Evaluate the Long-Term Safety of Astegolimab in Participants With Chronic Obstructive Pulmonary Disease (COPD)

NCT ID: NCT05878769

**Study Summary: Astegolimab for COPD** This clinical trial is investigating the long-term safety and effectiveness of a medication called astegolimab in people with Chronic Obstructive Pulmonary ...

Recruiting

Phase: PHASE3 Conditions: Chronic Obstructive Pulmonary Disease

Long-term Efficacy and Safety of Tozorakimab in Participants With Chronic Obstructive Pulmonary Disease With a History of Exacerbations (PROSPERO).

NCT ID: NCT05742802

This clinical trial, called PROSPERO, is researching the long-term effects and safety of a medication called Tozorakimab for adults with Chronic Obstructive Pulmonary Disease (COPD) who have experi...

Recruiting

Phase: PHASE3 Conditions: Chronic Obstructive Pulmonary Disease (COPD)

A Study to Evaluate the Efficacy and Safety Study of Povorcitinib in Participants With Inadequately Controlled Moderate to Severe Asthma

NCT ID: NCT05851443

This clinical trial is studying a medication called povorcitinib to see how well it works and how safe it is for people with moderate to severe asthma that is not well controlled with current treat...

Recruiting

Phase: PHASE2 Conditions: Moderate to Severe Asthma

Search All Trials Browse All Locations